PFTT@CM
| 【Numbering】BKMC106014 | 【CAS】CAS | ||
| 【Item No.】BKMC106014-2 | 【specification】 | ||
|
|||
Name: PFTT @ CM
Composition: Polyvinylpyrrolidone + Fe-TCPP + Cancer Cell Membranes (CM)
Size: 300-500nm
Application: Tumor therapy
Storage conditions: -4℃
Other instructions: sealed state shelf life for half a year [main advantage] PFTT @ CM using CM excellent immune clearance and homologous targeting ability], synthetic nano platform can through lysosome way by cancer cells endocytosis, activated by TME after release drugs, through iron, PDT, chemotherapy combined treatment, has strong anti-tumor response to breast cancer, in vitro and in vivo studies have confirmed.
Message
Composition: Polyvinylpyrrolidone + Fe-TCPP + Cancer Cell Membranes (CM)
Size: 300-500nm
Application: Tumor therapy
Storage conditions: -4℃
Other instructions: sealed state shelf life for half a year [main advantage] PFTT @ CM using CM excellent immune clearance and homologous targeting ability], synthetic nano platform can through lysosome way by cancer cells endocytosis, activated by TME after release drugs, through iron, PDT, chemotherapy combined treatment, has strong anti-tumor response to breast cancer, in vitro and in vivo studies have confirmed.
Title:Microenvironment-driven sequential ferroptosis, photodynamic therapy, and chemotherapy for targeted breast cancer therapy by a cancer-cell-membrane-coated nanoscale metal-organic framework
Article link:https://doi.org/10.1016/j.biomaterials.2022.121449
| Warm tips: Suzhou Beike nano products are only used for scientific research, not for human body,different batches of products have different specifications and performance |
Message
|
| Warm tips: Suzhou Beike nano products are only used for scientific research, not for human body,different batches of products have different specifications and performance.The website pictures are from the Internet. The pictures are for reference only. Please take the real object as the standard. In case of infringement, please contact us to delete them immediately. |
Previous： the end...
Next： 仿生巨噬细胞膜载CRISPR/Cas9
